FDA Approves Imatinib (Gleevec) for Pediatric ALL

The US Food and Drug Administration has approved imatinib (Gleevec) for the treatment of newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL) in children.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news